Peripartum cardiomyopathy (PPCM) is a relatively rare disease estimated to occur in one in 3000 to 4000 pregnancies. Criteria for diagnosis include (1) development of cardiac failure in the last trimester of pregnancy or within five months of delivery, (2) absence of a determinable aetiology for the cardiac failure and (3) absence of demonstrable heart disease prior to the last month of pregnancy 1 .
The aetiology of PPCM remains poorly understood although theories have generally centred around viral infection and autoimmune disease 1, 3, 5 .
We describe four patients presenting to the Royal Hospital for Women (RHW) between 1990 and 1994, who demonstrate some of the difficulties involved in the diagnosis and management of this disease. These women also demonstrate the spectrum of disease which presents to the obstetric anaesthetist. The successful outcome (in Cases 3 and 4) of women with a history of PPCM in previous pregnancies leads us to believe that our current practice of counselling against further pregnancy may be inappropriate. Further studies will be required to help identify those women who may safely attempt a further pregnancy, albeit under appropriate supervision.
CASE 1
A 34-year-old female, G1P0, delivered a healthy infant at term by normal vaginal delivery. Her pregnancy had been uncomplicated apart from episodic rapid palpitations and presyncope in the preceding eight weeks which continued after delivery. Holter monitoring showed episodes of Torsade de pointes and further investigation included an echocardiograph which showed moderate biventricular dilation with left ventricular fractional shortening (LVFS) of 14% (normal 28-38%). Myocardial biopsy was consistent with cardiomyopathy.
She was initially treated with atenolol for her arrhythmias and hydralazine was added after the echocardiograph results were known.
She required readmission four weeks post partum with near-syncopal episodes. Observations on admission were pulse rate 54/min, sinus rhythm, blood pressure 110/50 mmHg. There was no evidence of cardiac failure. Echocardiography now showed only borderline left ventricular dilation, a normal right ventricle and a LVFS of 35%. Return of normal cardiac function was confirmed by Gated Heart Pool Scan (GHPS) which showed a left ventricular ejection fraction (LVEF) of 66%. These near-syncopal episodes were thought to be related to her antihypertensive medications which were ceased and replaced with amiodarone.
She has subsequently remained symptom-free. Holter monitoring at nine weeks post partum showed only infrequent unifocal ventricular ectopic beats (VEB) and repeat GHPS at three months demonstrated an LVEF of 69%. Amiodarone was subsequently withdrawn. Twelve months later she was completely well and was seeking advice regarding further pregnancy.
CASE 2
An 18-year-old Aboriginal woman, G2P1, presented to a rural N.S.W. hospital in premature labour with a singleton breech at 34 weeks gestation. She had had one previous pregnancy resulting in normal vaginal delivery.
In the index pregnancy she received no antenatal care, was anaemic (Hb 6.7 gm/dl) and malnourished and had a positive VDRL and TPHA consistent with early latent syphilis. She was treated with intravenous penicillin and salbutamol, transfused with four units of packed cells and was transferred to RHW, where she delivered a stillborn child with non-immune fetal hydrops.
Following delivery she developed acute onset of hypertension, fever, oliguria, proteinuria, oedema and hyperreflexia. She was anaemic (haemoglobin 8.8 g/dl with raised white cell count of 30,000/mm 3 ) and prolonged coagulation parameters consistent with disseminated intravascular coagulation (DIC) and a rising creatinine. Arterial blood gases on room air showed PO 2 61 mmHg, PCO 2 25 mmHg, pH 7.42 and a base deficit of 6 consistent with hypoxaemia and metabolic acidosis. The associated respiratory alkalosis was most likely multi-factorial: compensation for metabolic acidosis and tissue hypoxia combined with hyperventilation secondary to late pregnancy physiological change and pain during delivery. The metabolic acidosis was thought to be secondary to an impaired circulation with salbutamol a possible contributing factor. Chest X-ray showed cardiomegaly and pulmonary venous congestion. Cardiac echo showed biventricular dilation with poor systolic function. She was treated with hydralazine, intravenous antibiotics (ampicillin, gentamicin, metronidazole) and transferred to an intensive care unit with multi-organ failure (cardiorespiratory, renal and haematological) against a backdrop of preeclampsia and sepsis.
She remained hypertensive in intensive care and had clinical evidence of cardiac failure. Initial pulmonary artery catheter measurements confirmed poor left ventricular function (central venous pressure (CVP) 10 mmHg, pulmonary capillary wedge pressure (PCWP) 22 mmHg, cardiac output 6 l/min. systemic vascular resistance 1465 dyn.s.cm -5 ).
The source of sepsis was thought to be pyosalpinx (confirmed on ultrasound and CT scan) and left lower lobe pulmonary consolidation. The sepsis responded to antibiotics without the need for surgical intervention. Antibiotics were ceased 17 days postdelivery.
Blood pressure was initially controlled with sodium nitroprusside and later captopril and nifedipine which were themselves ceased by three weeks post partum and she remained normotensive on no therapy. Although clinical resolution of cardiac failure occurred, a GHPS two weeks post partum showed mild global left ventricular dysfunction with LVEF of 50%, consistent with early cardiomyopathy. This required no specific intervention.
Her creatinine normalized by day 5 and the proteinuria had settled from 8 g/day to 2 g/day. A renal biopsy showed changes consistent with glomerular tuft disease, a form of glomerulonephritis which is steroid-responsive but often remits spontaneously.
She was advised not to fall pregnant for the time being and discharged only on the oral contraceptive pill. Unfortunately, she did not present for her outpatient appointment and was lost to follow-up.
CASE 3
A 28-year-old woman, G2P1, presented for caesarean section at 33 weeks gestation due to deteriorating cardiac function.
Her first pregnancy in 1991 had been complicated by cardiac failure with intra-uterine death at term. She had required inotropic support, intubation and ventilation with an estimated ejection fraction of 15% (LVFS 8%) during the acute illness. Although discharged home on enalapril, frusemide and digoxin, a progress echocardiogram at four months had shown little improvement. There was severe and generalized reduction in left ventricular contractility with a LVFS of 13%. She was advised not to attempt further pregnancies and was offered, but declined, placement on the cardiac transplant list.
She subsequently presented some twelve months later at 20 weeks gestation. Cardiac function was followed closely with her initial echocardiogram at this time showing marked improvement since 1991. Ventricular contraction was borderline normal and the estimated ejection fraction was 50% (LVFS of 25%). By 33 weeks, however, this had deteriorated to a LVFS of 19% with moderate dilation of the left ventricle and impaired systolic contractility on echocardiography, so early lower segment caesarean section was planned. Functionally, the patient noted mild orthopnoea and dyspnoea on moderate exertion. Observations on admission were pulse rate 84/minute, BP 110/75 mmHg. She had no signs of cardiac failure.
A pulmonary artery catheter was sited the day prior to surgery with initial results suggestive of intravascular volume depletion. CVP (referred to right atrium) was 0 mmHg, pulmonary artery pressure (PAP) 19/7 mmHg and PCWP was 6 mmHg. Fluids were titrated to maintain a CVP of 10 mmHg and, over six hours, a glyceryl trinitrate infusion was commenced and increased to a maximum of 0.66 µg/kg/min. Fluids were adjusted to maintain central pressures. This enabled peripheral dilation to be achieved while maintaining haemodynamic stability.
An epidural was then sited at L2-3 interspace via a 16 gauge Tuohy needle some ten hours prior to surgery. An infusion of bupivacaine 0.5% with fentanyl 4 µg/ml was commenced. The level of block was gradually increased to T4 by increasing the infusion rate from 4 to 10 ml per hour over a six-hour period while monitoring blood pressure, central venous pressure and pulmonary capillary wedge pressure. The patient was then transferred to the operating theatre. Caesarean section proceeded uneventfully with delivery of a well female infant. Postoperatively, bupivacaine 0.125% with fentanyl 5 µg/ml was infused via an epidural catheter for analgesia. Glyceryl trinitrate was slowly withdrawn in the six hours following surgery during which time central pressures continued to be monitored. Both the epidural and the pulmonary artery catheter were removed 24 hours after surgery. The patient was transferred to a general ward on day 3. Her postoperative course was uneventful apart from two brief episodes of dyspnoea on day 6 during which general observations and oxygen saturations were stable.
A progress echocardiogram on day 5 showed little change from the previous antenatal study with, possibly, a slight reduction in left ventricular dimensions and a LVFS of 20%. She was discharged home on day 9 on enalapril and dipyridamole. Twelve months later both she and the infant remain well.
CASE 4
A 31-year-old female, G6P4, presented at 26 weeks gestation, 13 months following cardiac transplant for PPCM. Her previous obstetric history included three normal vaginal deliveries at term with anti-D antibodies detected in her second pregnancy, one miscarriage at 12 weeks and, in her fifth (previous) pregnancy, the development of severe cardiac failure at 34 weeks gestation requiring emergency caesarean section, intubation and inotropic support (dobutamine, adrenaline and dopamine). She eventually required cardiac transplantation.
In her sixth (index) pregnancy, she presented at 26 weeks gestation with hypertension, a diastolic BP of 100 mmHg on admission. Her medications were cyclosporin, azathioprine, prednisone, captopril, aspirin, cholestyramine and flucloxacillinketoconazole. Laboratory investigations revealed renal impairment (creatinine peaked at 170 µmol/l), cholestasis (bilirubin peaked at >150 µmol/l, alkaline phosphate >500 IU/l) and hyperuricaemia. Fetal ultrasound showed oligohyramnios with normal fetal growth and normal flow indices. Her course in hospital was one of episodic hypertension to 200/115 mmHg, responsive to reduction of cyclosporin and introduction of hydralazine. Improvement in creatinine and liver function tests followed cessation of ketoconazole and azathioprine (with increased dose of prednisone to compensate) and a change from captopril to metoprolol. Follow-up uterine ultrasound showed a normal volume of liquor amnii.
After an eight-week stay, she was allowed home to be with her family on Christmas Day. During this time she developed vaginal bleeding and subsequently delivered a well female infant by normal vaginal delivery in a N.S.W. country hospital at 35 weeks gestation.
DISCUSSION
The aetiology and pathogenesis of PPCM remains largely theoretical and is generally centred upon viral and autoimmune mechanisms. It has been suggested that viral infection associated with altered immune status during pregnancy may trigger an autoimmune response in susceptible individuals. This is supported by the finding of a higher incidence of myocarditis in PPCM than in idiopathic dilated cardiomyopathy 7 .
There are no changes pathognomonic for PPCM and histopathology generally shows only non-specific findings: myocardial fibre hypertrophy and degeneration, interstitial oedema, lymphocytic infiltration 5,6 . The diagnosis consequently remains one of exclusion of other causes of cardiac failure in late pregnancy or the puerperium.
Between 1990 and 1994 at RHW there were ten cases of cardiomyopathy (Table 1 ) of which three met the criteria for diagnosis of PPCM. We have excluded Case 2 as at least four other factors may have contributed to the picture of cardiomyopathy-sepsis tocolytic therapy, nutritional factors and hypertension/pre-eclampsia. Indeed, according to the Hughes Criteria 16 , the presence of hypertension or preeclampsia specifically precludes a diagnosis of PPCM being made. This case therefore, illustrates the difficulties that arise in the diagnosis of more complicated cases, and although she has ongoing cardiac dysfunction in the face of the reversal of these other factors, we have placed Case 2 instead in the infectious/toxic category. This gives an incidence of PPCM at RHW of 0.01 to 0.02%, a figure generally in agreement with that of other authors 3 .
We have tended to discourage further pregnancies in PPCM due to fears of the haemodynamic changes of pregnancy causing further deterioration of already compromised cardiac function, or of recurrence of the immunologically mediated process causing relapse of PPCM. This "blanket" counselling has been applied even to cases where cardiac function has previously returned to normal, or when heart transplantation has taken place. Consequently, experience in this area is limited.
Demakis et al in 1971 2 showed that, prognostically, these women could be divided into two groups, depending on whether heart size had returned to normal by six months following delivery. This can be expected to occur in more than 50% of patients with conventional cardiac failure therapy. In those whose cardiomegaly persisted, prognosis was poor, with average length of survival being 4.7 years. In this group, subsequent pregnancy was likely to result in severe cardiac deterioration and death.
In those women whose heart size returned to normal, however, eight patients had 21 subsequent pregnancies with temporary deterioration of cardiac function in only two women and no deaths. Their conclusion was that only patients with persistent cardiac enlargement must avoid subsequent pregnancies.
More recently, Sutton et al 10 looked specifically at the effects of subsequent pregnancy on left ventricular function in four women with a history of PPCM whose left ventricular size and function had returned to normal by six months post partum (as judged by 2-D echocardiography). No patient developed any cardiac dysfunction during or after pregnancy. All (including one with twins) had normal babies. They concluded that subsequent pregnancies in this group need not be discouraged as long as regular clinical and echocardiographic assessments take place.
There has been a recent review of pregnancies in heart transplant recipients 15 . Of the 25 progressing past the first trimester, all resulted in live births, ten were pre-term, five were small for gestational age and only one infant had ongoing morbidity (mild spasticity). There were no maternal deaths but three mothers died within three years of delivery. Fortyeight per cent of women were chronically hypertensive and 24% (6) developed pre-eclampsia. Twelve per cent developed cholestatic jaundice while 8% (2) had transient renal insufficiency. It is of particular note that four patients had required their cardiac transplants secondary to PPCM in a previous pregnancy. None of these women suffered any cardiac dysfunction in the peripartum period.
Overall, pregnancies in heart transplant recipients do have a higher rate of complications and should be considered high risk, but in most cases a successful outcome can be expected. There is no evidence that women who have received their cardiac allograft secondary to PPCM should be considered at any greater risk or counselled differently from those with transplants as a result of other pathology.
There are only a few case reports in the literature regarding anaesthetic management for caesarean section in PPCM. Some authors have argued the case for general anaesthesia in severe cases as "cardiac reserve is considered so limited that any reduction in systemic vascular resistance due to epidural blockade could be catastrophic" 13 . Others have argued the case for regional anaesthesia on the basis that a reduction in afterload may be beneficial in a situation of poor ventricular function, where no outflow tract obstruction is present 14 .
We could concur with the latter view and, as described in Case 3, would favour the technique of a slowly titrated epidural while monitoring haemodynamic parameters with a pulmonary artery catheter, and judicious use of fluids to maintain optimal filling pressures. In the particular case we describe, glyceryl trinitrate was commenced after fluid loading to optimize preload and to enable peripheral dilation to be achieved in a controlled manner. Later introduction of epidural bupivacaine would be expected to cause minimal change in haemodynamic parameters.
We believe the advantages of epidural anaesthesia in PPCM are threefold: a. It avoids the need for either cardiodepressant drugs such as thiopentone and the inhalational anaesthetic agents, or high-dose opioid techniques, which, while they maintain haemodynamic stability, necessitate postoperative ventilation for both mother and infant. In addition, the management of a failed intubation would be made more complicated by the use of high-dose longer-acting opioids. b. Epidural anaesthesia may be induced slowly in a gradual and controlled manner while adjustments to fluids and inotropes, if necessary, may be titrated to maintain optimum filling pressures and cardiac output. This is particularly advantageous in this population due to the susceptibility of pregnant women to aspiration of gastric contents, which makes slow intravenous induction of anaesthesia more difficult. c. Major centro-neuraxial blockade may actually improve myocardial performance by reducing the afterload on the left ventricle without impairing contractility.
The successful outcome of the three cases of PPCM described and a review of the available literature have made us re-evaluate the advice we currently give to these women to avoid further pregnancies. The evidence seems to suggest, at least in those whose heart size can be demonstrated to return to normal within six months, that a further pregnancy may be safely undertaken. In these patients, frequent clinical assessment, regular echocardiographic assessment and close collaboration between obstetrician, physician and anaesthetist must form the mainstay of antenatal and intrapartum management.
